Shikha Srivastava

Title: Innovator Profile: Shikha Srivastava

Introduction

Shikha Srivastava, based in Norman, Oklahoma, has made significant contributions to the field of antimicrobial research. As an accomplished inventor, she holds a patent that showcases her innovative work in developing compounds that combat various pathogens.

Latest Patents

Shikha's patent, titled "Antimicrobial peptides and methods of use," includes cyclic depsipeptide-class molecules known as persephacins, along with their analogs. These compounds exhibit remarkable antimicrobial properties, specifically antifungal activity against a wide range of clinically relevant fungal pathogens, antiprotozoan parasite activity, and antibacterial activity. Notably, persephacins can be utilized in treating difficult-to-treat ocular fungal infections at lower concentrations compared to traditional treatments like natamycin. The formulation may also involve the inclusion of a secondary compound.

Career Highlights

Shikha currently works at the University of Oklahoma, where her research focuses on antimicrobial peptides and their applications. Her innovative mindset and dedication have positioned her as a notable figure in her field.

Collaborations

Throughout her career, Shikha has collaborated with esteemed colleagues, including Robert H. Cichewicz and Lin Du. These partnerships have further enriched her research and contributed to the advancement of antimicrobial solutions.

Conclusion

Shikha Srivastava is an inspiring inventor whose work in antimicrobial research has the potential to revolutionize treatments for resistant pathogens. With her patent and ongoing research at the University of Oklahoma, she continues to pave the way for innovative solutions in healthcare.